Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.1K Buy
3,457
+90
+3% +$1.4K ﹤0.01% 2327
2026
Q1
$42.4K Buy
3,367
+19
+0.6% +$193 ﹤0.01% 2293
2025
Q4
$29.1K Sell
3,348
-214
-6% -$1.86K ﹤0.01% 2409
2025
Q3
$33.4K Sell
3,562
-20
-0.6% -$186 ﹤0.01% 2244
2025
Q2
$32.1K Buy
3,582
+445
+14% +$3.55K ﹤0.01% 2209
2025
Q1
$27.4K Sell
3,137
-36
-1% -$362 ﹤0.01% 2207
2024
Q4
$26.4K Buy
3,173
+48
+2% +$354 ﹤0.01% 2113
2024
Q3
$18.5K Buy
3,125
+1,642
+111% +$9.14K ﹤0.01% 2151
2024
Q2
$7.8K Sell
1,483
-298
-17% -$1.52K ﹤0.01% 2370
2024
Q1
$9.69K Buy
1,781
+795
+81% +$5.07K ﹤0.01% 2083
2023
Q4
$6.18K Buy
+986
New +$6.5K ﹤0.01% 2140

Other funds holding ADTN

GAMMA Investing's ADTN Position: Q2 2026 in Review

GAMMA Investing increased its Adtran (ADTN) stake by 2.7% in Q2 2026, buying an estimated $1.4K and bringing the position to 3,457 shares worth $48.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2327.

GAMMA Investing first reported a position in ADTN in Q4 2023 and has held it in 11 quarters since. 249 funds tracked by Wall St. Rank hold ADTN as of Q2 2026.

  • GAMMA Investing held 3,457 shares of Adtran worth $48.1K as of Q2 2026.
  • GAMMA Investing bought 90 Adtran shares in Q2 2026, an estimated $1.4K.
  • Adtran made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2327 holding.
  • GAMMA Investing first reported a position in Adtran in Q4 2023 and has held it in 11 quarters since.
  • 249 funds tracked by Wall St. Rank held Adtran as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.